Shuji Muramatsu

Title: Shuji Muramatsu: Innovator in NF-κB Research

Introduction

Shuji Muramatsu is a prominent inventor based in Fuji, Japan. He has made significant contributions to the field of molecular biology, particularly in the study of NF-κB, a protein complex that plays a crucial role in regulating immune response and cell survival. With a total of 2 patents, his work has implications for diagnosing and treating various diseases.

Latest Patents

Muramatsu's latest patents focus on the NF-κB activating gene. These patents provide proteins that exhibit NF-κB activity, which are essential for diagnosing, treating, or preventing diseases linked to the excessive activation or inhibition of NF-κB. Utilizing plasmid pNF-κB-Luc, he has cloned cDNA encoding a protein capable of activating NF-κB from a cDNA library derived from human lung fibroblasts. The DNA sequence and the deduced amino acid sequence have been determined, making these innovations valuable for screening substances that inhibit or promote NF-κB activation.

Career Highlights

Shuji Muramatsu is affiliated with Asahi Kasei Pharma Corporation, where he continues to advance research in his field. His work has garnered attention for its potential applications in therapeutic development and disease management.

Collaborations

Muramatsu collaborates with notable colleagues, including Akio Matsuda and Goichi Honda, who contribute to his research endeavors and enhance the impact of his innovations.

Conclusion

Shuji Muramatsu's contributions to NF-κB research exemplify the importance of innovation in the medical field. His patents and ongoing work hold promise for future advancements in disease treatment and prevention.